Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Breast Neoplasms | Phase 1 | ClinicalTrials |
| Prostatic Neoplasms | Phase 1 | ClinicalTrials |
| Melanoma | Phase 1 | ClinicalTrials |
| Prostatic Neoplasms | Phase 1 | ClinicalTrials |
| Prostatic Neoplasms | Phase 1 | ClinicalTrials |
| Fallopian Tube Neoplasms | Phase 1 | ClinicalTrials |
| Adenocarcinoma; Colorectal Neoplasms; Pancreatic Neoplasms | Phase 1 | ClinicalTrials |
| Melanoma | Phase 2 | ClinicalTrials |
| Melanoma | Phase 3 | ClinicalTrials |
| Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid | Phase 2 | ClinicalTrials |
| Prostatic Neoplasms | Phase 2 | ClinicalTrials |
| Lung Neoplasms; Small Cell Lung Carcinoma | Phase 2 | ClinicalTrials |
CONTENTS